| 21 | STEVENS, MARY JEANNASHVILLE, TN · 37215 | NATIONAL ACCOUNT DIRECTOR · EXELIXIS | TRUMP NATIONAL COMMITTEE JFC, INC.C00873893 | 2025-11-18 | $48 | Primary (P) | Filing 1943543FEC filing ↗ |
| 22 | STEVENS, MARY JEANNASHVILLE, TN · 37215 | NATIONAL ACCOUNT DIRECTOR · EXELIXIS | TRUMP NATIONAL COMMITTEE JFC, INC.C00873893 | 2025-09-18 | $48 | Primary (P) | Filing 1943543FEC filing ↗ |
| 23 | STEVENS, MARY JEANNASHVILLE, TN · 37215 | NATIONAL ACCOUNT DIRECTOR · EXELIXIS | TRUMP NATIONAL COMMITTEE JFC, INC.C00873893 | 2025-04-18 | $48 | Primary (P) | Filing 1909599FEC filing ↗ |
| 24 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-12-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1943892FEC filing ↗ |
| 25 | BREGMAN, DAVIDLAWRENCE TOWNSHIP, NJ · 08648 | PHARMA · EXELIXIS | DNC SERVICES CORP / DEMOCRATIC NATIONAL COMMITTEEC00010603 | 2025-07-16 | $100 | General 2025 (G2025) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1912670FEC filing ↗ |
| 26 | BREGMAN, DAVIDOCALA, FL · 34475 | PHARMACOVIGILANCE STRATEGY LEADER · EXELIXIS | JON OSSOFF FOR SENATEC00718866 | 2026-06-30 | $100 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1996824FEC filing ↗ |
| 27 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-04-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1903362FEC filing ↗ |
| 28 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-09-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1921631FEC filing ↗ |
| 29 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-06-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1903362FEC filing ↗ |
| 30 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-11-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1943892FEC filing ↗ |
| 31 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-05-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1903362FEC filing ↗ |
| 32 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-10-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1943892FEC filing ↗ |
| 33 | BREGMAN, DAVIDOCALA, FL · 34475 | PHARMACEUTICAL DRUG DEVELOPMENT · EXELIXIS | DSCCC00042366 | 2026-05-04 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1985956FEC filing ↗ |
| 34 | BREGMAN, DAVIDOCALA, FL · 34475 | PHARMACOVIGILANCE STRATEGY LEADER · EXELIXIS | JON OSSOFF FOR SENATEC00718866 | 2026-06-17 | $100 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1996824FEC filing ↗ |
| 35 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-07-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1921631FEC filing ↗ |
| 36 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-03-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1888100FEC filing ↗ |
| 37 | HUBBARD, SUSANWINDSOR, CA · 95492 | EVP PUBLIC AFFAIRS & INVESTOR RELATION · EXELIXIS | HARRIS VICTORY FUNDC00744946 | 2025-08-05 | $100 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1921631FEC filing ↗ |
| 38 | SHIPLEY, JAMIEFAYETTEVILLE, AR · 72701 | COMMERCIAL · EXELIXIS | HAMILTON FOR KANSASC00948901 | 2026-06-28 | $207 | Primary 2026 (P2026) | Filing 1997753FEC filing ↗ |
| 39 | EVES, PATRICKPHILADELPHIA, PA · 19125 | PHARMACEUTICAL R&D · EXELIXIS | ACTBLUEC00401224 | 2026-03-23 | $250 | Primary (P) | EARMARKED FOR DGA ACTION (C00503789)Filing 1970198FEC filing ↗ |
| 40 | EVES, PATRICK T.PHILADELPHIA, PA · 19125 | PHARMACEUTICAL R&D · EXELIXIS | DGA ACTIONC00503789 | 2026-03-23 | $250 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1970133FEC filing ↗ |